novabay.com - נכסים נקיים למניה בודדת NBY

Partnerships with pharmacy chains and ophthalmologists are driving sales, as illustrated by the equity per share chart, where the latest mark stands at -2.24. NovaBay Pharmaceuticals (NBY) is creating unique Avenova antimicrobial formulations by investing in safe formulas. Diversified warehouse hubs in the US bolster business stability, completely eliminating component supply disruptions.

Book value per share reflects the portion of net assets attributable to a single security, allowing an investor to assess the intrinsic value of the business net of all liabilities. The trend in book value per share confirms the capitalization of NovaBay Pharmaceuticals (NBY), which is growing through the implementation of energy-efficient ESG standards and the optimization of production chains within the ophthalmology sector.